- Home
- VREX
as of 03-06-2026 3:56pm EST
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 580.6M | IPO Year: | 2016 |
| Target Price: | $16.67 | AVG Volume (30 days): | 349.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.05 | EPS Growth: | -45.30 |
| 52 Week Low/High: | $6.76 - $14.56 | Next Earning Date: | 05-12-2026 |
| Revenue: | $811,000,000 | Revenue Growth: | -9.22% |
| Revenue Growth (this year): | 5.35% | Revenue Growth (next year): | 3.88% |
| P/E Ratio: | 251.80 | Index: | N/A |
| Free Cash Flow: | 18.8M | FCF Growth: | N/A |
AI-Powered VREX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 10, 2026 · 100% conf.
Q4 2025 Earnings
8-K SELLFeb 10, 2026 · 100% conf.
1D
-9.35%
$12.83
5D
-9.21%
$12.85
20D
-9.17%
$12.85
vrex-202602100001681622false1678 S. Pioneer RoadSalt Lake CityUtah8410400016816222026-02-102026-02-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2026
VAREX IMAGING CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 001-37860 81-3434516
(State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification Number)
1678 S. Pioneer Road, Salt Lake City, Utah 84104 (Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (801) 972-5000 Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common StockVREXThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02Results of Operations and Financial Condition
On February 10, 2026, Varex Imaging Corporation (the “Company”) issued a press release announcing its preliminary results of operations for the three months ended January 2, 2026 entitled: “Varex Announces Financial Results for First Quarter Fiscal Year 2026.” A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference into this item.
This information shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01Financial Statements and Exhibits
(d) Exhibits
Exhibit No.Description 99.1Press Release dated February 10, 2026, entitled "Varex Announces Financial Results for First Quarter Fiscal Year 2026"
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
VAREX IMAGING CORPORATION
Dated: February 10, 2026 By:/s/ Matthew A. Martinez Matthew A. Martinez Chief Legal Officer and Corporate Secretary
2025 Q3 Q3 2025 Earnings
8-K Nov 18, 2025
Q3 2025 Earnings
8-KNov 18, 2025
vrex-202511180001681622false1678 S. Pioneer RoadSalt Lake CityUtah8410400016816222025-11-182025-11-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2025
VAREX IMAGING CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 001-37860 81-3434516
(State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification Number)
1678 S. Pioneer Road, Salt Lake City, Utah 84104 (Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (801) 972-5000 Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common StockVREXThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02Results of Operations and Financial Condition
On November 18, 2025, Varex Imaging Corporation (the “Company”) issued a press release announcing its preliminary results of operations for the twelve months ended October 3, 2025 entitled: “Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025.” A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference into this item.
This information shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01Financial Statements and Exhibits
(d) Exhibits
Exhibit No.Description 99.1Press Release dated November 18, 2025, entitled "Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025"
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
VAREX IMAGING CORPORATION
Dated: November 18, 2025 By:/s/ Matthew A. Martinez Matthew A. Martinez Chief Legal Officer and Corporate Secretary
2025 Q2 Q2 2025 Earnings
8-K Aug 7, 2025
Q2 2025 Earnings
8-KAug 7, 2025
vrex-202508070001681622false1678 S. Pioneer RoadSalt Lake CityUtah8410400016816222025-08-072025-08-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025
VAREX IMAGING CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 001-37860 81-3434516
(State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification Number)
1678 S. Pioneer Road, Salt Lake City, Utah 84104 (Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (801) 972-5000 Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common StockVREXThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02Results of Operations and Financial Condition
On August 7, 2025, Varex Imaging Corporation (the “Company”) issued a press release announcing its preliminary results of operations for the three and nine months ended July 4, 2025 entitled: “Varex Announces Financial Results for Third Quarter Fiscal Year 2025.” A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference into this item.
This information shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01Financial Statements and Exhibits
(d) Exhibits
Exhibit No.Description 99.1Press Release dated August 7, 2025, entitled "Varex Announces Financial Results for Third Quarter Fiscal Year 2025"
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
VAREX IMAGING CORPORATION
Dated: August 7, 2025 By:/s/ Kimberley E. Honeysett Kimberley E. Honeysett Chief Legal Officer, General Counsel, and Corporate Secretary
Compare VREX vs Leading Stocks
See how VREX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "VREX Varex Imaging Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.